Old Web
English
Sign In
Acemap
>
Paper
>
Safety and Efficacy of Tinostamustine in Heavily Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)
Safety and Efficacy of Tinostamustine in Heavily Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)
2021
Hervé Ghesquières
Antonio Pinto
Anna Sureda
Olivier Tournilhac
Franck Morschhauser
Tomáš Janík
Pier Luigi Zinzani
Keywords:
Internal medicine
Oncology
hodgkin lymphoma
relapsed refractory
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]